Trends in Molecular Medicine
ReviewHIF-1 and tumor progression: pathophysiology and therapeutics
Section snippets
Molecular and cellular biology of HIF-1
HIF-1 is a heterodimer composed of HIF-1α and HIF-1β subunits, which are basic helix–loop–helix–PAS domain proteins. HIF-1β is constitutively expressed, whereas the expression of HIF-1α is maintained at low levels in most cells under normoxic conditions (Fig. 1). The negative regulation of HIF-1α expression results from the activity of oxygen-dependent prolyl hydroxylases that modify residues 564 and 402 [7]. This enzymatic modification of HIF-1α is required for the binding of the von
Mechanisms and consequences of HIF-1α overexpression in human cancers
Immunohistochemical analysis of human tumor biopsies revealed dramatic overexpression of HIF-1α in common cancers 16., 17.; this is a consequence of both intra-tumoral hypoxia and genetic alterations (Table 1). Whereas hypoxia is a universal stimulus for HIF-1α expression, the effect of genetic alterations (other than VHL loss-of-function) appears to depend on the signal transduction pathways that are active in a particular tumor cell. These data provide a molecular mechanism linking oncogene
Therapeutic implications
The recent data regarding the role of HIF-1 in tumor progression have important clinical implications. First, as described above, immunohistochemical analysis of tumor biopsies for HIF-1α expression might provide prognostic information and identify subsets of patients requiring aggressive therapy that would not be offered to the general patient population because the increased side-effects seen in all patients would offset the survival benefits seen in the high-risk subgroup. This scenario
Concluding remarks
Anti-angiogenic therapy is a promising new approach (Box 1), although concerns have been raised that it will select for highly aggressive, hypoxia-adapted tumor cells [36]. The assumption that selection for endothelial cells that are resistant to the therapy is unlikely to occur has been called into question by the identification of mutations affecting proteins in apoptotic pathways in endothelial cells of patients with primary pulmonary hypertension [37]. The combination of an anti-angiogenic
References (37)
- et al.
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Cell
(1996) Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology
Trends Mol. Med.
(2001)C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation
Cell
(2001)The expression and distribution of the hypoxia-inducible transcription factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages
Am. J. Pathol.
(2000)Hypoxia-inducible factor-1 (HIF-1) mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKBF3) gene: its possible role in the Warburg effect
J. Biol. Chem.
(2002)- et al.
The p14ARF tumor suppressor protein facilitates nucleolar sequestration of hypoxia-inducible factor-1α (HIF-1(α) and inhibits HIF-1-mediated transcription
J. Biol. Chem.
(2001) Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies
Mol. Med. Today
(2000)- et al.
Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects
J. Natl. Cancer Inst.
(2001) Transcription factor HIF-1 is a necessary mediator of the Pasteur effect in mammalian cells
Mol. Cell. Biol.
(2001)Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
Genes Dev.
(2000)
Suppression of tumor growth through disruption of hypoxia-inducible transcription
Nat. Med.
HIFα targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing
Science
Targeting of HIF-α to the von Hippel–Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
Science
HIF-1α protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations
Proc. Natl. Acad. Sci. U.S.A.
FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity
Genes Dev.
Asparagine hydroxylation of the HIF transactivation domain: a hypoxic switch
Science
HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression
Mol. Cell. Biol.
Modulation of HIF-1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics
Cancer Res.
Cited by (957)
Dapagliflozin attenuates myocardial hypertrophy via activating the SIRT1/HIF-1α signaling pathway
2023, Biomedicine and PharmacotherapyHypoxia-responsive nanocarriers for chemotherapy sensitization via dual-mode inhibition of hypoxia-inducible factor-1 alpha
2022, Journal of Colloid and Interface ScienceIntegrated approach to elucidate metal-implant related adverse outcome pathways
2022, Regulatory Toxicology and Pharmacology